Pointe Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,364
| Closed | -$288K | – | 164 |
|
|
2023
Q4 | $288K | Sell |
2,364
-1,548
| -40% | -$173K | 0.2% | 118 |
|
|
2023
Q3 | $439K | Buy |
3,912
+12
| +0.3% | +$1.52K | 0.32% | 75 |
|
|
2023
Q2 | $568K | Sell |
3,900
-159
| -4% | -$21.6K | 0.43% | 61 |
|
|
2023
Q1 | $524K | Sell |
4,059
-1,596
| -28% | -$200K | 0.38% | 63 |
|
|
2022
Q4 | $721K | Buy |
5,655
+121
| +2% | +$14K | 0.55% | 44 |
|
|
2022
Q3 | $579K | Buy |
5,534
+1,655
| +43% | +$182K | 0.46% | 57 |
|
|
2022
Q2 | $407K | Hold |
3,879
| – | – | 0.3% | 86 |
|
|
2022
Q1 | $496K | Sell |
3,879
-49
| -1% | -$5.91K | 0.32% | 84 |
|
|
2021
Q4 | $485K | Sell |
3,928
-427
| -10% | -$55.9K | 0.3% | 88 |
|
|
2021
Q3 | $619K | Buy |
4,355
+41
| +1% | +$6.03K | 0.43% | 67 |
|
|
2021
Q2 | $674K | Sell |
4,314
-259
| -6% | -$42K | 0.47% | 58 |
|
|
2021
Q1 | $711K | Sell |
4,573
-25
| -0.5% | -$3.87K | 0.5% | 45 |
|
|
2020
Q4 | $688K | Sell |
4,598
-438
| -9% | -$61.9K | 0.59% | 43 |
|
|
2020
Q3 | $666K | Buy |
5,036
+506
| +11% | +$66.1K | 0.58% | 47 |
|
|
2020
Q2 | $525K | Buy |
4,530
+9
| +0.2% | +$1.04K | 0.47% | 59 |
|
|
2020
Q1 | $444K | Sell |
4,521
-161
| -3% | -$21.1K | 0.43% | 59 |
|
|
2019
Q4 | $680K | Sell |
4,682
-14
| -0.3% | -$1.93K | 0.57% | 52 |
|
|
2019
Q3 | $626K | Buy |
4,696
+611
| +15% | +$78.9K | 0.53% | 55 |
|
|
2019
Q2 | $467K | Sell |
4,085
-96
| -2% | -$11.2K | 0.38% | 75 |
|
|
2019
Q1 | $518K | Buy |
4,181
+382
| +10% | +$43.4K | 0.44% | 68 |
|
|
2018
Q4 | $383K | Sell |
3,799
-80
| -2% | -$9K | 0.37% | 81 |
|
|
2018
Q3 | $495K | Buy |
3,879
+505
| +15% | +$60K | 0.39% | 77 |
|
|
2018
Q2 | $365K | Sell |
3,374
-566
| -14% | -$61.6K | 0.31% | 93 |
|
|
2018
Q1 | $417K | Buy |
3,940
+27
| +0.7% | +$3.14K | 0.36% | 85 |
|
|
2017
Q4 | $458K | Sell |
3,913
-100
| -2% | -$11.3K | 0.37% | 80 |
|
|
2017
Q3 | $456K | Buy |
4,013
+31
| +0.8% | +$3.58K | 0.34% | 87 |
|
|
2017
Q2 | $496K | Buy |
3,982
+1,123
| +39% | +$133K | 0.36% | 85 |
|
|
2017
Q1 | $339K | Buy |
+2,859
| New | +$324K | 0.26% | 109 |
|
|
2016
Q4 | – | Sell |
-2,705
| Closed | -$341K | – | 233 |
|
|
2016
Q3 | $341K | Buy |
2,705
+22
| +0.8% | +$2.72K | 0.25% | 114 |
|
|
2016
Q2 | $314K | Buy |
+2,683
| New | +$304K | 0.23% | 122 |
|
Other funds holding ZBH
Pointe Capital Management's ZBH Position: Q1 2024 in Review
Pointe Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 2,364 shares — an estimated $288K sold.
Pointe Capital Management first reported a position in ZBH in Q2 2016 and held it in 30 quarters. The position peaked at $721K in Q4 2022. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.
- Pointe Capital Management reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
- Pointe Capital Management sold 2,364 Zimmer Biomet shares in Q1 2024, an estimated $288K.
- Pointe Capital Management first reported a position in Zimmer Biomet in Q2 2016 and held it in 30 quarters.
- Pointe Capital Management's Zimmer Biomet position peaked at $721K in Q4 2022.
- 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.
Based on Pointe Capital Management's 13F filing for Q1 2024, filed 7 May 2024.